These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 22698414)
1. New directions in cardiovascular risk assessment: the role of secondary risk stratification markers. Wierzbicki AS Int J Clin Pract; 2012 Jul; 66(7):622-30. PubMed ID: 22698414 [TBL] [Abstract][Full Text] [Related]
2. Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study. Agarwala A; Virani S; Couper D; Chambless L; Boerwinkle E; Astor BC; Hoogeveen RC; Coresh J; Sharrett AR; Folsom AR; Mosley T; Ballantyne CM; Nambi V Atherosclerosis; 2016 Oct; 253():156-163. PubMed ID: 27665201 [TBL] [Abstract][Full Text] [Related]
3. Early markers of cardiovascular risk in chronic kidney disease. Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527 [TBL] [Abstract][Full Text] [Related]
4. Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA). Blaha MJ; Cainzos-Achirica M; Greenland P; McEvoy JW; Blankstein R; Budoff MJ; Dardari Z; Sibley CT; Burke GL; Kronmal RA; Szklo M; Blumenthal RS; Nasir K Circulation; 2016 Mar; 133(9):849-58. PubMed ID: 26801055 [TBL] [Abstract][Full Text] [Related]
5. Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study. Tonkin AM; Blankenberg S; Kirby A; Zeller T; Colquhoun DM; Funke-Kaiser A; Hague W; Hunt D; Keech AC; Nestel P; Stewart R; Sullivan DR; Thompson PL; West M; White HD; Simes J; Int J Cardiol; 2015 Dec; 201():499-507. PubMed ID: 26318511 [TBL] [Abstract][Full Text] [Related]
6. Intake of Vitamin K Antagonists and Worsening of Cardiac and Vascular Disease: Results From the Population-Based Gutenberg Health Study. Eggebrecht L; Prochaska JH; Schulz A; Arnold N; Jünger C; Göbel S; Laubert-Reh D; Binder H; Beutel ME; Pfeiffer N; Blankenberg S; Lackner KJ; Spronk HM; Ten Cate H; Münzel T; Wild PS J Am Heart Assoc; 2018 Sep; 7(17):e008650. PubMed ID: 30371151 [TBL] [Abstract][Full Text] [Related]
7. Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors: US Preventive Services Task Force Recommendation Statement. ; Curry SJ; Krist AH; Owens DK; Barry MJ; Caughey AB; Davidson KW; Doubeni CA; Epling JW; Kemper AR; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Tseng CW; Wong JB JAMA; 2018 Jul; 320(3):272-280. PubMed ID: 29998297 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Kavousi M; Elias-Smale S; Rutten JH; Leening MJ; Vliegenthart R; Verwoert GC; Krestin GP; Oudkerk M; de Maat MP; Leebeek FW; Mattace-Raso FU; Lindemans J; Hofman A; Steyerberg EW; van der Lugt A; van den Meiracker AH; Witteman JC Ann Intern Med; 2012 Mar; 156(6):438-44. PubMed ID: 22431676 [TBL] [Abstract][Full Text] [Related]
9. Integrating Biomarkers and Imaging for Cardiovascular Disease Risk Assessment in Diabetes. Tehrani DM; Wong ND Curr Cardiol Rep; 2016 Nov; 18(11):105. PubMed ID: 27612474 [TBL] [Abstract][Full Text] [Related]
10. Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers. Eggers KM; Kempf T; Venge P; Wallentin L; Wollert KC; Lindahl B Am Heart J; 2010 Jul; 160(1):88-94. PubMed ID: 20598977 [TBL] [Abstract][Full Text] [Related]
11. How to identify patients with vulnerable plaques. Virani SS; Ballantyne CM Diabetes Obes Metab; 2008 Sep; 10(10):824-33. PubMed ID: 17970757 [TBL] [Abstract][Full Text] [Related]
12. Microvascular function predicts cardiovascular events in primary prevention: long-term results from the Firefighters and Their Endothelium (FATE) study. Anderson TJ; Charbonneau F; Title LM; Buithieu J; Rose MS; Conradson H; Hildebrand K; Fung M; Verma S; Lonn EM Circulation; 2011 Jan; 123(2):163-9. PubMed ID: 21200002 [TBL] [Abstract][Full Text] [Related]
13. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. Zethelius B; Berglund L; Sundström J; Ingelsson E; Basu S; Larsson A; Venge P; Arnlöv J N Engl J Med; 2008 May; 358(20):2107-16. PubMed ID: 18480203 [TBL] [Abstract][Full Text] [Related]
14. Risk stratification and selection for statin therapy: going beyond Framingham. Fitchett DH; Mancini GB; Gregoire J; Anderson T; McPherson R Can J Cardiol; 2014 Jun; 30(6):667-70. PubMed ID: 24882539 [TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population. Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR Eur Heart J; 2007 Jun; 28(11):1374-81. PubMed ID: 17242007 [TBL] [Abstract][Full Text] [Related]
16. Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure. Alehagen U; Dahlström U; Rehfeld JF; Goetze JP J Card Fail; 2013 Jan; 19(1):31-9. PubMed ID: 23273592 [TBL] [Abstract][Full Text] [Related]
17. Combining risk markers improves cardiovascular risk prediction in women. Holewijn S; den Heijer M; Kiemeney LA; Stalenhoef AF; de Graaf J Clin Sci (Lond); 2014 Jan; 126(2):139-46. PubMed ID: 23879211 [TBL] [Abstract][Full Text] [Related]
18. Gender-based cardiometabolic risk evaluation in minority and non-minority men grading the evidence of non-traditional determinants of cardiovascular risk. Billups KL; Miner MM; Wierzbicki AS; Jackson G Int J Clin Pract; 2011 Feb; 65(2):134-47. PubMed ID: 21199197 [TBL] [Abstract][Full Text] [Related]
19. Associations of plasma natriuretic peptide, adrenomedullin, and homocysteine levels with alterations in arterial stiffness: the Framingham Heart Study. Levy D; Hwang SJ; Kayalar A; Benjamin EJ; Vasan RS; Parise H; Larson MG; Wang TJ; Selhub J; Jacques PF; Vita JA; Keyes MJ; Mitchell GF Circulation; 2007 Jun; 115(24):3079-85. PubMed ID: 17533184 [TBL] [Abstract][Full Text] [Related]
20. [Biomarkers in cardiology--state of the art 2007]. Mair J Wien Med Wochenschr; 2007 Feb; 157(3-4):48-56. PubMed ID: 17340059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]